Theralase Technologies Inc.
TLTFF
$0.11
$0.004.46%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.51% | 6.06% | 2.68% | 8.15% | 3.80% |
| Total Depreciation and Amortization | -7.65% | -8.25% | -7.90% | -6.32% | -6.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 36.35% | 15.09% | -8.77% | -15.76% | -13.94% |
| Change in Net Operating Assets | 243.23% | -52.53% | 279.32% | 121.81% | -82.67% |
| Cash from Operations | 40.32% | 6.18% | 37.75% | 19.13% | -4.83% |
| Capital Expenditure | -283.33% | -224.75% | -164.19% | 47.46% | 72.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -283.33% | -224.75% | -164.19% | 47.46% | 72.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.58% | -8.24% | -4.30% | 0.09% | -6.01% |
| Issuance of Common Stock | -44.81% | -13.30% | -29.00% | 33.54% | 130.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -150.00% | 100.00% |
| Cash from Financing | -45.39% | -15.74% | -31.50% | 33.63% | 135.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -355.46% | -2,234.38% | 109.69% | 115.31% | 104.20% |